Table 1. Complication rate between TPPB and TRPB and between TPPB groups 1 and 2.
| Complication | Transperineal (N=283) | Transrectal (N=513) | p value |
|---|---|---|---|
| All – no. (%) | 156 (55.1) | 420 (81.9) | <0.001 |
| Hematuria – no. (%) | 138 (48.8) | 340 (66.3) | <0.001 |
| Rectal bleeding – no. (%) | 10 (3.5) | 93 (18.1) | <0.001 |
| Pain without need of analgesia – no. (%) | 12 (4.2) | 48 (9.4) | 0.009 |
| Pain requiring analgesia – no. (%) | 12 (4.2) | 23 (4.5) | 0.87 |
| Urinary retention – no. (%) | 3 (1.1) | 12 (2.3) | 0.20 |
| Prostatitis – no. (%) | 0 | 3 (0.6) | 0.56 |
| Other – no. (%) | 7 (2.5) | 15 (2.9) | 0.71 |
| Complication | TPPB Group 1 (N=142) | TPPB Group 2 (N=141) | p value |
| All – no. (%) | 95 (66.9) | 61 (43.3) | <0.001 |
| Hematuria – no. (%) | 84 (59.2) | 54 (38.3) | <0.001 |
| Rectal bleeding – no. (%) | 9 (6.3) | 1 (0.7) | 0.02 |
| Pain without need of analgesia – no. (%) | 8 (5.6) | 4 (2.8) | 0.24 |
| Pain requiring analgesia – no. (%) | 8 (5.6) | 4 (2.8) | 0.24 |
| Urinary retention – no. (%) | 2 (1.4) | 1 (0.7) | >0.99 |
| Prostatitis – no. (%) | 0 | 0 | - |
| Other – no. (%) | 3 (2.1) | 4 (2.8) | 0.712 |
TPPB = transperineal prostate biopsy; TRPB = transrectal prostate biopsy; no = number; % = percentage Group 1: TPPB y in the first 6 months (March to August 2021); Group 2: TPPB in the following 6 months (September 2021 to February 2022)